Literature DB >> 11428981

Reactivation of chronic Chagas' disease following allogeneic bone marrow transplantation and successful pre-emptive therapy with benznidazole.

J Altclas1, A Sinagra, G Jaimovich, C Salgueira, C Luna, A Requejo, V Milovic, A De Rissio, L Feldman, A Riarte.   

Abstract

This report shows the early detection of reactivation of chronic Chagas' disease (CCd) in a 27-year-old man with chronic myelogenous leukemia undergoing allogeneic bone marrow transplantation (ABMT). Pre-emptive therapy with benznidazole during a period of 7 weeks led to a rapid recovery of the patient, who remains free of parasitemia 2 years after the bone marrow transplantation.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 11428981     DOI： 10.1034/j.1399-3062.1999.010207.x

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN： 1398-2273            Impact factor:   2.228


  11 in total

Review 1.  Transmission of tropical and geographically restricted infections during solid-organ transplantation.

Authors:  P Martín-Dávila; J Fortún; R López-Vélez; F Norman; M Montes de Oca; P Zamarrón; M I González; A Moreno; T Pumarola; G Garrido; A Candela; S Moreno
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

2.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

Review 3.  Parasitic central nervous system infections in immunocompromised hosts.

Authors:  Melanie Walker; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2005-03-02       Impact factor: 9.079

Review 4.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 5.  Trypanosoma cruzi infection: a review with emphasis on cutaneous manifestations.

Authors:  Vagish Hemmige; Herbert Tanowitz; Aisha Sethi
Journal:  Int J Dermatol       Date:  2012-05       Impact factor: 2.736

6.  Therapy of chagas disease: implications for levels of prevention.

Authors:  Sergio Sosa-Estani; Lisandro Colantonio; Elsa Leonor Segura
Journal:  J Trop Med       Date:  2012-03-05

Review 7.  Parasitic Infections in Hematopoietic Stem Cell Transplantation.

Authors:  Isidro Jarque; Miguel Salavert; Javier Pemán
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-07-01       Impact factor: 2.576

8.  Reactivation of Chagas Disease in a Patient With an Autoimmune Rheumatic Disease: Case Report and Review of the Literature.

Authors:  Mary M Czech; Ashwin K Nayak; Kavitha Subramanian; Jose F Suarez; Jessica Ferguson; Karen Blake Jacobson; Susan P Montgomery; Michael Chang; Gordon H Bae; Shyam S Raghavan; Hannah Wang; Eugenia Miranti; Indre Budvytiene; Stanford Mervyn Shoor; Niaz Banaei; Kerri Rieger; Stan Deresinski; Marisa Holubar; Brian G Blackburn
Journal:  Open Forum Infect Dis       Date:  2021-02-05       Impact factor: 4.423

9.  Chagas disease reactivation: cutaneous manifestations in a transplanted patient.

Authors:  Maria Guillermina Ferraresso; Ana Clara Torre; Maria Manuela Martínez Piva; Laura Barcan
Journal:  An Bras Dermatol       Date:  2018 Nov/Dec       Impact factor: 1.896

10.  Trypanosoma cruzi infection associated with atypical clinical manifestation during the acute phase of the Chagas disease.

Authors:  Lucia Rangel-Gamboa; Lirio López-García; Francisco Moreno-Sánchez; Irma Hoyo-Ulloa; María Elisa Vega-Mémije; Nancy Mendoza-Bazán; Mirza Romero-Valdovinos; Angélica Olivo-Díaz; Guiehdani Villalobos; Fernando Martínez-Hernández
Journal:  Parasit Vectors       Date:  2019-10-30       Impact factor: 3.876
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.